Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: Dizziness; runny nose; Body aches; Slight fever of almost a 100°F; Chills/Shivering; Hypersensitivity reaction; Chest tightness; Heart rate increased; Face flushed almost immediately/face was very warm; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness), FLUSHING (Face flushed almost immediately/face was very warm), RHINORRHOEA (runny nose), CHEST DISCOMFORT (Chest tightness) and HEART RATE INCREASED (Heart rate increased) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 076C21A, 039K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, High cholesterol, Joint disorder and Heart disorder. Concomitant products included UBIDECARENONE (COQ 10) from 01-Jan-2019 to an unknown date for Heart disorder, EZETIMIBE (ZETIA) from 01-Jan-2020 to an unknown date for High cholesterol, LOSARTAN from 01-Jan-2019 to an unknown date for Hypertension, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) from 01-Jan-2019 to an unknown date for Joint disorder, ASPIRIN [ACETYLSALICYLIC ACID] from 01-Jan-2020 to an unknown date for Prophylactic.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, the patient experienced FLUSHING (Face flushed almost immediately/face was very warm). 03-Nov-2021, the patient experienced CHEST DISCOMFORT (Chest tightness) and HEART RATE INCREASED (Heart rate increased). On 03-Nov-2021 at 7:00 AM, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On 04-Nov-2021, the patient experienced DIZZINESS (Dizziness), MYALGIA (Body aches) and PYREXIA (Slight fever of almost a 100°F). 04-Nov-2021, the patient experienced RHINORRHOEA (runny nose) and CHILLS (Chills/Shivering). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 04-Nov-2021, CHEST DISCOMFORT (Chest tightness), HEART RATE INCREASED (Heart rate increased) and HYPERSENSITIVITY (Hypersensitivity reaction) had resolved. At the time of the report, DIZZINESS (Dizziness), RHINORRHOEA (runny nose), MYALGIA (Body aches) and PYREXIA (Slight fever of almost a 100°F) outcome was unknown and FLUSHING (Face flushed almost immediately/face was very warm) and CHILLS (Chills/Shivering) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Nov-2021, Blood pressure measurement: 118/68 (Low) Low. On 04-Nov-2021, Body temperature: 99.9 (High) 99.9°F. On 04-Nov-2021, Heart rate: 111 (High) 111 at one point, when usually patient has 70 and 90 (High) around 90, when usually patient has 70. On 05-Nov-2021, Body temperature: 97.8 (High) 97.8°F. On 05-Nov-2021, Heart rate: 72 (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Usual heart beat of patient was 70. Patient race was given.   This case was linked to MOD-2021-375391 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Upon follow-up receipt: Patient initial was updated. On 10-Nov-2021: Upon follow-up receipt: Added Patient demographic details. Added Medical history conditions. Lab data was updated. Concomitant medications were added. Events were added (Chest tightness, Heart rate increased, Hypersensitivity reaction), Outcome of some events.